Meet the Expert Team at Prolindox
Our team consists of highly skilled professionals with years of experience in their respective fields.
Founder and Scientific Adviser: Herbert Weissbach, Ph.D.,
Professor Emeritus, Florida Atlantic University. Dr. Weissbach is recognized internationally as a leader in the broad field of oxidative damage. Among his many honors and awards he is a Member of the National Academy of Sciences, American Academy of Microbiology and National Academy of Inventors. He is a former VP of Research at Hoffmann-La Roche and co-founder and Director of the Roche Institute of Molecular Biology (RIMB). After retiring from Roche, he founded and was Director of the Center for Molecular Biology and Biotechnology at Florida Atlantic University. Dr. Weissbach has authored over 460 scientific articles and book chapters.
Subramanian Iyer, Ph.D., Chief Executive Officer,
Affiliate Member of the Center for Molecular Biology and Biotechnology at Florida Atlantic Univ. Serial entrepreneur with 20 + year leadership positions. Cofounder and CSO of ProdIgY Biotech, a company that has successfully completed its preclinical research and is ready for Series A funding to embark on clinical trials. He has several publications in top tier journals and over a dozen patents.
Donald Fishbein: Chief Business Officer.
A highly successful entrepreneur, providing customized business advisory solutions for emerging ophthalmology companies, including commercial development. Successfully created strategic roadmaps for all aspects of initial product launch.
Adrian Rabinowicz: M.D. Medical Advisor.
Highly accomplished executive with 23+ years of success leading medical product development, US and ex-US regulatory submissions, and product launches for biotech / pharmaceutical companies. Directed and organized all clinical development activities from human proof of concept through Phase 4 programs.
Lawrence Weissbach, Ph.D., Scientific Advisor.
Extensive research and pharmaceutical operational background covering cancer translational research, management of preclinical research contracts and academic/industry alliances, outsourced CRO studies, and consulting. Previously an Assistant Professor/Principal Investigator at Massachusetts General Hospital, focusing on cancer biology, inflammation, and drug discovery.